STERIS (STE)
The price, the headline numbers and the latest news, in one place.
STERIS (STE) Stock Price, Analysis & Data
| Bid | 235.84 |
| Market Cap | 23.07B |
| Revenue (ttm) | 6.04B |
| Net Income (ttm) | 805M |
| 0.91 | |
| 8.18 | |
| 28.93 | |
| 19.32 | |
| P/B (ttm) | 3.20 |
| P/S (ttm) | 3.82 |
| Earnings Date | Nov 4, 2026 |
| Ask | 236.86 |
| Volume | 29,741 |
| Avg. Volume (20D) | 783,128 |
| Open | 234.67 |
| Previous Close | 236.44 |
| Day's Range | 234.35 - 237.39 |
| 52-Week Range | 195.14 - 269.44 |
| Analyst | Buy |
| Price Target | 269.5 (13.90%) |
| Dividends | $2.58 (1.09%) |
| Ex-Dividend Date | Sep 4, 2026 |
About STE
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipm...
Financial Performance
In 2026, STERIS's revenue was 5.94B, an increase of 8.73% compared to the previous year's 5.46B. Earnings were 782.3M, an increase of 27.27%.
Financial StatementsAnalyst Forecast
According to 8 analyst ratings, the average rating for STE stock is "Buy". The 12-month stock price forecast is 269.5, which is upside of 13.9% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of $1.49B misses estimates by $0, with 7.30% YoY growth.
- EPS of 2.59 exceeds estimates by 0.10, with 10.68% YoY growth.
Analysts project revenue of ... Upgrade
